Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Acquisitions: 2019-2023

Historic Acquisitions for LifeStance Health (LFST) over the last 4 years, with FY2023 value amounting to $19.8 million.

  • LifeStance Health's Acquisitions fell 1361.95% to $19.8 million in Q1 2023 from the same period last year, while for Dec 2023 it was $19.8 million, marking a year-over-year decrease of 6707.97%. This contributed to the annual value of $19.8 million for FY2023, which is 6707.97% down from last year.
  • As of FY2023, LifeStance Health's Acquisitions stood at $19.8 million, which was down 6707.97% from $60.2 million recorded in FY2022.
  • In the past 5 years, LifeStance Health's Acquisitions registered a high of $99.6 million during FY2021, and its lowest value of $19.8 million during FY2023.
  • For the 4-year period, LifeStance Health's Acquisitions averaged around $59.7 million, with its median value being $59.6 million (2019).
  • Its Acquisitions has fluctuated over the past 5 years, first crashed by 3954.25% in 2022, then tumbled by 6707.97% in 2023.
  • Annual analysis of 4 years shows LifeStance Health's Acquisitions stood at $59.1 million in 2019, then skyrocketed by 68.61% to $99.6 million in 2021, then plummeted by 39.54% to $60.2 million in 2022, then tumbled by 67.08% to $19.8 million in 2023.
  • Its last three reported values are $19.8 million in FY2023, $60.2 million for FY2022, and $99.6 million during FY2021.